About Yunnan Baiyao (81.49, 0.49, 0.60%) to modify the drug instructions, recently triggered widespread concern in the market.
China Anti-Aging Suppliers
Here you can find the related products in Anti-Aging, we are professional manufacturer of Anti-Aging. We focused on international export product development, production and sales. We have improved quality control processes of Anti-Aging to ensure each export qualified product.
If you want to know more about the products in Anti-Aging, please click the Product details to view parameters, models, pictures, prices and Other information about Anti-Aging.
Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Anti-Aging!
Here you can find the related products in Anti-Aging, we are professional manufacturer of Anti-Aging. We focused on international export product development, production and sales.
Acetyl Hexapeptide-8,achirellin,polypeptide, Anti-Aging,peptide Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com
According to a report on April 2, Yunnan Baiyao recently revised its drug product specification and clearly stated that its formula contains "Caowu" ingredients. Aconitum is also known as heartbroken grass, and its main component is aconitine, which is highly toxic. As early as February 2013, Yunnan Baiyao was found in Hong Kong containing unlabeled aconitine alkaloids (the main component of Aconitum), and the Hong Kong Department of Health and the Macau Health Bureau immediately issued a ban on the sale and recovery of Yunnan Baiyao. command.
Since Yunnan Baiyao is classified as a national security product, according to the relevant provisions of the state secrecy laws and regulations, the specifications and labels of those classified as national secrets may not be listed as component items. Therefore, Yunnan Baiyao has always been very secretive about the formula of baiyao. This is the first time that Yunnan Baiyao has revised the drug label and acknowledged that it contains Aconitum.
When there was a lot of market discussion, Yunnan Baiyao announced today (April 8th) that according to the requirements of the State Food and Drug Administration's “Notice on Amendments to the Instructions for the Labeling of Chinese Medicines Containing Toxic Chinese Herbal Medicines,†the company’s relevant drug instruction manuals were revised Completed at the end of December 2013.
At the same time, Yunnan Baiyao also issued two previous instructions on the safety of Yunnan Baiyao. On February 6, 2013, Yunnan Baiyao explained the aconitine substances and issued data: “From 2010 to 2012, A total of 100 million bottles of Yunnanbaiyao (4g/bottle) and 1.7 billion tablets of Yunnan Baiyao capsules (0.25g/grain) were produced and sold. The company actively monitored adverse reactions. During the three years, a total of Yunnanbaiyao and Yunnanbaiyao capsules were detected. A total of 28 cases of adverse reactions were mainly manifested as skin irritation, itching, etc.; serious adverse reactions were not detected, and the effectiveness and safety of the product were undoubtedly.â€
On the other hand, after extensive public concern on the part of the Department of Health of Hong Kong in February 2013 regarding the disposal of some white drug products, the Hong Kong Department of Health has agreed to resume the shelves after the listed companies cooperated with the Hong Kong Department of Health to supplement the relevant product registration procedures. In November of this year, it resumed its normal sales in Hong Kong. Yunnan Baiyao also reiterated that Yunnan Baiyao products are safe and effective.
In order to understand more information on the Baiyao drugs, the reporter has repeatedly called the Yunnan Baiyao Dong Wei secretary's mobile phone, but as of press time, his phone has never been answered.
The reporter noticed that after several years of continuous rise, Yunnan Baiyao’s stock price peaked at RMB 119.30 per share in October last year and since then it has continued to fall. As of the previous trading day’s closing price of RMB 81.49 per share, Yunnan Baiyao was In half a year, the stock price fell more than 30%.